Abeona Therapeutics (PCJ) Q4 2024 Earnings Report

0 Followers

CH:PCJ Q4 2024 EPS Results

Actual EPS: CHF 0.41
Consensus EPS: -CHF 0.28
Beat/Miss: Beat by +CHF 0.69
One Year Ago EPS: -CHF 0.48

CH:PCJ Q4 2024 Revenue Results

Actual Revenue: CHF 0
Expected Revenue: CHF 81.43K
Beat/Miss: Missed by -CHF 81.43K
YoY Revenue Growth: ―

Earnings Announcement Details

Quarter: Q4 2024
Date: 03/20/2025
Time: Before Open
Conference Call: Thursday, March 20, 2025

CH:PCJ Upcoming Earnings

Abeona Therapeutics's next earnings date is estimated for November 16, 2026, based on past reporting schedules.

Q4 2024 Earnings Call Audio

CH:PCJ Q4 2024 Earnings Call

0:00 / 0:00

Q4 2024 Earnings Slide Deck

No slide deck is available for this earnings event.

Q4 2024 Earnings Call Summary

No earnings call summary is available for this earnings event.

CH:PCJ Earnings History

CH:PCJ earnings history
Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Press Release
Nov 16, 2026	2026 (Q3)	-0.14-	-0.08	―	―
Aug 13, 2026	2026 (Q2)	-0.19-0.28	1.39	-120.47% (-1.68)
May 13, 2026	2026 (Q1)	-0.27-0.24	-0.2	-25.00% (-0.05)
Mar 17, 2026	2025 (Q4)	-0.29-0.29	0.41	-172.00% (-0.70)
Nov 12, 2025	2025 (Q3)	-0.23-0.08	-0.51	84.13% (+0.43)
Aug 14, 2025	2025 (Q2)	-0.321.39	-0.21	757.69% (+1.60)
May 15, 2025	2025 (Q1)	-0.29-0.20	-0.94	79.31% (+0.75)
Mar 20, 2025	2024 (Q4)	-0.280.41	-0.48	184.75% (+0.89)
Nov 14, 2024	2024 (Q3)	-0.33-0.51	-0.39	-31.25% (-0.12)
Aug 12, 2024	2024 (Q2)	-0.28-0.21	-0.75	71.74% (+0.54)
May 15, 2024	2024 (Q1)	-0.42-0.94	-0.44	-114.81% (-0.50)
Mar 18, 2024	2023 (Q4)	-0.38-0.48	-0.05	-821.88% (-0.43)
Nov 13, 2023	2023 (Q3)	-0.43-0.39	-1.21	67.57% (+0.81)
Aug 08, 2023	2023 (Q2)	-0.55-0.75	-1.69	55.77% (+0.94)
May 11, 2023	2023 (Q1)	-0.50-0.44	-2.85	84.57% (+2.41)
Mar 29, 2023	2022 (Q4)	-0.61-0.05	-9.16	99.43% (+9.11)
Nov 14, 2022	2022 (Q3)	-1.42-1.21	-1.42	15.43% (+0.22)
Aug 11, 2022	2022 (Q2)	-1.53-1.69	-3.26	48.00% (+1.56)
May 13, 2022	2021 (Q4)	-1.93-2.85	-3.46	17.65% (+0.61)
May 13, 2022	2022 (Q1)	―-	-3.46	―
Nov 15, 2021	2021 (Q3)	-3.26-1.42	-1.63	12.50% (+0.20)
Jul 28, 2021	2021 (Q2)	-3.32-3.26	-2.85	-14.29% (-0.41)
May 18, 2021	2021 (Q1)	―-3.46	-10.59	67.31% (+7.12)
Mar 24, 2021	2020 (Q4)	―-3.46	-6.11	43.33% (+2.65)
Nov 09, 2020	2020 (Q3)	―-1.63	-7.12	77.14% (+5.50)
Aug 10, 2020	2020 (Q2)	―-2.85	-9.97	71.43% (+7.12)
May 06, 2020	2020 (Q1)	―-10.59	-7.94	-33.33% (-2.65)
Mar 16, 2020	2019 (Q4)	―-6.11	-7.33	16.67% (+1.22)
Nov 12, 2019	2019 (Q3)	―-7.12	-6.92	-2.94% (-0.20)
Aug 09, 2019	2019 (Q2)	―-9.97	-5.09	-96.00% (-4.89)
May 10, 2019	2019 (Q1)	―-7.94	-3.66	-116.67% (-4.27)
Mar 18, 2019	2018 (Q4)	―-7.33	-3.87	-89.47% (-3.46)
Nov 09, 2018	2018 (Q3)	―-6.92	-2.65	-161.54% (-4.27)
Aug 09, 2018	2018 (Q2)	―-5.09	-4.27	-19.05% (-0.81)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed

Abeona Therapeutics earnings date